About Us


Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in healthcare in approximately 80 countries.

Contact Us

Lisa Cruz
Patient Advocacy & Engagement Lead – Leukemia & Lung Cancer
US & Global Patient Advocacy & Engagement
Email: Lisa.Cruz@takeda.com

Scott Campbell
Patient Advocacy & Engagement Lead – Multiple Myeloma & Cell Therapies
US & Global Patient Advocacy & Engagement
Email: Scott.Campbell@takeda.com

Company Address:
40 Landsdowne Street
Cambridge, MA 02139